# Pharmacokinetics Study on Nevirapine Resistance in Tanzania

> **NCT00294892** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 144 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** carbamazepine and nevirapine
- **DRUG:** Nevirapine

## Key facts

- **NCT ID:** NCT00294892
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2009-09
- **Final completion:** 2010-06
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2020-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00294892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00294892, "Pharmacokinetics Study on Nevirapine Resistance in Tanzania". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00294892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*